Designed for:

neuroscience, biology, pharmacology, DMPK, PKPD and translational development teams seeking to evaluate, implement and de-risk CNS delivery approaches within therapeutic programs.

Explore biodistribution, target engagement, in vitro and in vivo models, dose translation, safety assessment and disease-specific case studies to understand how delivery technologies perform in real-world development settings.